Pharmacokinetic studies of intravenous glycosylated recombinant human granulocyte colony-stimulating factor in various hematological disorders: Inverse correlation between the half-life and bone marrow myeloid cell pool

International Journal of Hematology

Volumn 66, Issue 1, 1997, Pages 57-67

  Watari, Kiyoshi ^a   Ozawa, Keiya ^b   Takahashi, Satoshi ^a   Tojo, Arinobu ^a   Tani, Kenzaburo ^a   Kamachi, Shin ichi ^c   Asano, Shigetaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Glycosylated; Half life; Hematological disorders; Pharmacokinetics; Recombinant human granulocyte colony stimulating factor (rhG CSF)

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA;

EID: 0031194591     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(97)00576-8     Document Type: Article

References (28)

1. Asano S. Human granulocyte colony-stimulating factor: its basic aspects and clinical applications. Am J Pediatr Hematol Oncol 1991;13:400-413.
2. Gabrilove J. The development of granulocyte colony-stimulating factor in its various clinical applications. Blood 1992;80:1382-1385.
3. Yoshida Y, Hirashima K, Asano S, Takaku F. A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes. Br J Haematol 1991;78:378-384.
4. Bonilla MA, Gillio AP, Ruggeiro M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989;320:1574-1580.
5. Jakubowski AA, Souza L, Kelly F, et al. Effects of human granulocyte colony-stimulating factor on neutropenia in patients with idiopathic neutropenia. N Engl J Med 1989;320:38-42.
6. Hammond WP IV, Price TH, Souza LM, Dale DC. Treatment of cyclic neutropenia with granulocyte colony-stimulating factor. N Engl J Med 1989;320:1306-1311.
7. Gabrilove JL, Jakubowski A, Fain K, et al. Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. J Clin Invest 1988;82:1454-1461.
8. Eguchi K, Shinkai T, Sasaki Y, et al. Subcutaneous administration of recombinant human granulocyte colony-stimulating factor (KRN8601) in intensive chemotherapy for patients with advanced lung cancer. Jpn J Cancer Res 1990;81:1168-1174.
9. Yoshida T, Nakamura S, Ohtake S, et al. Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma. Cancer 1990;66:1904-1909.
10. Pettengell R, Gurney H, Radford JA, et al. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood 1992;80:1430-1436.
11. Asano S, Masaoka T, Takaku F. Beneficial effect of recombinant human glycosylated granulocyte colony-stimulating factor in marrow-transplanted patients: results of multicenter phase II-III studies. Transplant Proc 1991;23:1701-1703.
12. Watari K, Asano S, Shirafuji N, et al. Serum granulocyte colony-stimulating factor in healthy volunteers and patients with various disorders. Blood 1989;73:117.
13. Kiriyama R, Chichibu K, Matsuno T, Ohsawa N. Sensitive chemiluminescent immunoassay for human granulocyte colony-stimulating factor in clinical applications. Clin Chim Acta 1993;220:201-209.
14. Aoyagi S, Arasawa K, Matsuyuki A, Kamachi S, Fukushima M, Ohsawa N. Chemiluminescence sandwich enzyme immunoassay for determination of human granulocyte colony stimulating factor (G-CSF). J Biolumin Chemilumin 1995;10:345-351.
15. Layton JE, Hockman H, Sheridan WP, Morstyn G. Evidence for a novel in vivo control mechanism of granulopoiesis: mature-cell related control of a regulatory growth factor. Blood 1989;74:1303-1307.
16. Stute N, Santana VM, Rodman JH, Schell MJ, Ihle JN, Evans WE. Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children. Blood 1992;79:2849-2854.
17. Kearns CM, Wang WC, Stute N, Ihle JN, Evans WE. Disposition of recombinant human granulocyte colony-stimulating factor in children with severe chronic neutropenia. J Pediatr 1993;123:471-479.
18. Irie S, Ogura H, Okamoto S, et al. Case report: alternation therapy with antileukemic agents and recombinant human granulocyte colony-stimulating factor for RAEB in transformation. Am J Med Sci 1992;303:316-318.
19. Motojima H, Kobayashi T, Kamachi S, Fukushima M, Wakabayashi K. Quantitative enzyme immunoassay for human granulocyte colony-stimulating factor (G-CSF). J Immunol Methods 1989;118:187-192.
20. Yamaoka K, Tanigawara Y, Nakagawa T, Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharmacobiodyn 1981;4:879-885.
21. Yuo A, Kitagawa S, Osawa A, et al. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 1989;74:2144-2149.
22. Shirafuji N, Asano S, Matsuda S, Watari K, Takaku F, Nagata S. A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders. Exp Hematol 1989;17:116-119.
23. Kawakami M, Tsutsumi H, Kumakawa T, et al. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 1990;76:1962-1964.
24. Pauksen K, Elfman L, Ulfgren AK, Venge P. Serum levels of granulocyte-colony stimulating factor (G-CSF) in bacterial and viral infections, and in atypical pneumonia. Br J Haematol 1994;88:256-260.
25. Bussolino F, Wang JM, Deffilipi P, et al. Granulocyte and granulocyte-macrophage-colony stimulating factor induce human endothelial cells to migrate and proliferate. Nature 1989;337:471-473.
26. Shimoda K, Okamura S, Harada N, et al. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J Clin Invest 1993;91:1310-1313.
27. 125I-G-CSF in Rats. Jpn Pharmacol Ther 1990;18(Suppl 9):459-470 (Japanese).
28. Tanaka H, Tokiwa T. Influence of renal and hepatic failure in the pharmacokinetics of recombinant human granulocyte colony-stimulating factor (KRN 8601) in the rat. Cancer Res 1990;50:6615-6619.